Paragonix Technologies
Clinical trials sponsored by Paragonix Technologies, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Device aims to keep donor livers healthier for transplant Results expected Aug 2027 (estimated)
-
Can Device-Preserved donor lungs boost transplant success?
Disease control By invitation onlyThis registry collects data on lung transplant patients whose donor lungs were preserved and transported using the LUNGguard or BAROguard devices. Researchers track outcomes such as primary graft dysfunction, rejection, survival, ICU and hospital stays, readmissions, and time on …
Sponsor: Paragonix Technologies • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Device aims to keep donor livers healthier for transplant
Disease control By invitation onlyResearchers are collecting data on how well donor livers preserved with the LIVERguard device function after transplantation. The study includes liver transplant recipients whose donor organs were stored in the device, as well as a comparison group of patients who received livers…
Sponsor: Paragonix Technologies • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC